The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
Open accessAbstract
Tumour hypoxia is increasingly recognized as a major deleterious factor in cancer therapies, as it compromises treatment and drives malignant progression. This review seeks to clarify the oxygen levels that are pertinent to this issue. It is argued that normoxia (20% oxygen) is an extremely poor comparator for "physoxia", i.e. the much lower levels of oxygen universally found in normal tissues, which averages about 5% oxygen, and ranges from about 3% to 7.4%. Importantly, it should be recognized that the median oxygenation in untreated tumours is significantly much lower, falling between approximately 0.3% and 4.2% oxygen, with most tumours exhibiting median oxygen levels <2%. This is partially dependent on the tissue of origin, and it is notable that many prostate and pancreatic tumours are profoundly hypoxic. In addition, therapy can induce even further, often unrecognized, changes in tumour oxygenation that may vary longitudinally, increasing or decreasing during treatment in ways that are not always predictable. Studies that fail to take cognizance of the actual physiological levels of oxygen in tissues (approximately 5%) and tumours (approximately 1%) may fail to identify the real circumstances driving tumour response to treatment and/or malignant progression. This can be of particular importance in genetic studies in vitro when comparison to human tumours is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced oxygen tension activates a conserved hypoxic signaling network centered on hypoxia-inducible factors (HIFs)”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, both physiological and pathological states can transiently disrupt the equilibrium between oxygen supply and demand, resulting in tissue and cellular hypoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In liver metastases of colorectal cancer, the median PO2 was 6 mmHg as compared with 30 mmHg in normal liver tissue (20).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“This response features extensive transcriptional reprogramming aimed at preserving cellular integrity under low-oxygen conditions”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Pàez‐Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,373
Research works printed but not linked: 8
- Vaupel P, 2010, Exp Oncol, 32, 125
- Vaupel P, 2003, Cancer Res, 63, 7634
- Höckel M, 1991, Cancer Res, 51, 6098
- Kallinowski F, 1995, Tumor oxygenation, 291
- Kallinowski F, 1995, Tumor oxygenation, 205
- Vaupel P, 2006, Eur J Gynaecol Oncol, 27, 142
- Stone JE, 2005, Eur J Gynaecol Oncol, 26, 31
- Cairns RA, 2001, Cancer Res, 61, 8903
Cited by
Sorted by citations
Items 201–300 of 1,000
Gutsche, K., Randi, E. B., Blank, V., Fink, D. A., Wenger, R. H., Leo, C., & Scholz, C. C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.002 · Cited by 44
Matherly, L. H., Hou, Z., & Gangjee, A. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3473-8 · Cited by 44
Kumar, B., Adebayo, A. K., Prasad, M. S., Capitano, M. L., Wang, R., Bhat‐Nakshatri, P., Anjanappa, M., Simpson, E. R., Chen, D., Liu, Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh3375 · Cited by 45
Wang, S., Wu, X., Zhang, Y., Zhang, D., Xie, B., Pan, Z., Ouyang, K., & Peng, T. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00356a · Cited by 44
Effect and mechanism of circRNAs in tumor angiogenesis and clinical application
Zhao, L., Guo, Y., Guo, Y., Ji, X., Fan, D., Chen, C., Yuan, W., Sun, Z., & Ji, Z. (2021) · International Journal of Cancer · doi:10.1002/ijc.33863 · Cited by 43
The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · Cancers · doi:10.3390/cancers14194870 · Cited by 43
Ma, Y., & Fenton, O. S. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c02584 · Cited by 44
Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities
Byrne, N. M., Summers, M. A., & McDonald, M. M. (2018) · JBMR Plus · doi:10.1002/jbm4.10125 · Cited by 47
Adav, S. S., & Sze, S. K. (2020) · Aging and Disease · doi:10.14336/ad.2019.0604 · Cited by 44
Involvement of JNK/FOXO1 pathway in apoptosis induced by severe hypoxia in porcine granulosa cells
Liu, Z., Li, C., Wu, G., Li, W., Zhang, X., Zhou, J., Zhang, L., Tao, J., Shen, M., & Liu, H. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.05.019 · Cited by 45
Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2
Heinz, A., Nonnenmacher, Y., Henne, A., Khalil, M., Bejkollari, K., Dostert, C., Hosseini, S., Goldmann, O., He, W., Palorini, R., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166530 · Cited by 42
IL-17A and IL-17F orchestrate macrophages to promote lung cancer
Ferreira, N. L. C., Mesquita, I., Baltazar, F., Silvestre, R., & Granja, S. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00510-y · Cited by 42
Bery, F., Figiel, S., Kouba, S., Fontaine, D., Guéguinou, M., Potier‐Cartereau, M., Vandier, C., Guibon, R., Bruyère, F., Fromont, G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134786 · Cited by 42
Bolland, H. R., Ma, T. S., Ramlee, S., Ramadan, K., & Hammond, E. M. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200861 · Cited by 44
Close, D. A., & Johnston, P. A. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2021.10.008 · Cited by 40
Molecular basis and clinical implications of HIFs in cardiovascular diseases
Hu, Y., Lu, H., Li, H., & Ge, J. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.09.004 · Cited by 42
Calcium signalling pathways in prostate cancer initiation and progression
Silvestri, R., Nicolì, V., Gangadharannambiar, P., Crea, F., & Bootman, M. D. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00738-x · Cited by 43
Hillestad, T., Hompland, T., Fjeldbo, C. S., Skingen, V. E., Salberg, U. B., Aarnes, E., Nilsen, A., Lund, K. V., Evensen, T. S., Kristensen, G. B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0950 · Cited by 41
Shi, Z., To, S. K. Y., Zhang, S., Deng, S., Artemenko, M., Zhang, M., Tang, J., Zeng, J.-Z., & Wong, A. S. T. (2021) · Theranostics · doi:10.7150/thno.52190 · Cited by 41
Cramer, T., & Vaupel, P. W. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.028 · Cited by 41
Parmakhtiar, B., Burger, R. A., Kim, J.-H., & Fruehauf, J. P. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1109 · Cited by 40
Bhattacharya, S., Calar, K., Evans, C. M., Petrasko, M., & de la Puente, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.01040 · Cited by 39
Smart strategies to overcome tumor hypoxia toward the enhancement of cancer therapy
Xu, M., Wang, P., Sun, S., Gao, L., Sun, L., Zhang, L., Zhang, J., Wang, S., & Liang, X. (2020) · Nanoscale · doi:10.1039/d0nr05501h · Cited by 40
Al-Hilal, T. A., Hossain, M. A., Alobaida, A., Alam, F., Keshavarz, A., Nozik‐Grayck, E., Stenmark, K. R., German, N., & Ahsan, F. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.030 · Cited by 40
Erkkilä, M. T., Bauer, B., Hecker‐Denschlag, N., Madera Medina, M. J., Leitgeb, R. A., Unterhuber, A., Gesperger, J., Roetzer, T., Hauger, C., Drexler, W., et al. (2019) · Journal of Biophotonics · doi:10.1002/jbio.201800378 · Cited by 39
Jarrett, A. M., Bloom, M. J., Godfrey, W. H., Syed, A., Ekrut, D. A., Ehrlich, L. I. R., Yankeelov, T. E., & Sorace, A. G. (2018) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqy014 · Cited by 41
Choi, J., Kwon, H., Lee, J., Lee, Y., Seoh, J., & Han, P. (2019) · Aging Cell · doi:10.1111/acel.12888 · Cited by 39
Dendrimer-Based Nanoparticulate Delivery System for Cancer Therapy
Shukla, R., Singh, A. P., Pardhi, V. P., Kashyap, K., Dubey, S. K., Dandela, R., & Kesharwani, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816963-6.00011-x · Cited by 39
Radical recombination and antioxidants: a hypothesis on the FLASH effect mechanism
Hu, A., Qiu, R., Li, W. B., Zhou, W., Wu, Z., Zhang, H., & Li, J. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2110307 · Cited by 38
Advances in Ferritin Physiology and Possible Implications in Bacterial Infection
Gehrer, C. M., Mitterstiller, A., Grubwieser, P., Meyron‐Holtz, E. G., Weiß, G., & Nairz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054659 · Cited by 42
The Warburg effect: The hacked mitochondrial-nuclear communication in cancer
Jiang, H., & Ye, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.006 · Cited by 40
Liew, H., Mein, S., Đokić, I., Haberer, T., Debus, J., Abdollahi, A., & Mairani, A. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.12.048 · Cited by 38
Design, Synthesis, and Utility of Defined Molecular Scaffolds
Sato, D., Wu, Z., Fujita, H., & Lindsey, J. S. (2021) · Organics · doi:10.3390/org2030013 · Cited by 40
In vitro assays for investigating the FLASH effect
Adrian, G., Ruan, J.-L., Paillas, S., Cooper, C. R., & Petersson, K. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.5 · Cited by 38
Flavonoids and cellular stress: a complex interplay affecting human health
Vissenaekens, H., Criel, H., Grootaert, C., Raes, K., Smagghe, G. J., & Camp, J. V. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1929822 · Cited by 40
Sunnerberg, J. P., Zhang, R., Gladstone, D. J., Swartz, H. M., Gui, J., & Pogue, B. W. (2023) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ace877 · Cited by 37
Brown, B. A., Myers, P. J., Adair, S. J., Pitarresi, J. R., Sah‐Teli, S. K., Campbell, L. A., Hart, W. S., Barbeau, M. C., Leong, K. M., Seyler, N. M., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-22-2945 · Cited by 40
Petronek, M. S., Stolwijk, J. M., Murray, S., Steinbach, E. J., Zakharia, Y., Buettner, G. R., Spitz, D. R., & Allen, B. G. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101864 · Cited by 41
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
Jarrar, Y., Zihlif, M., Al Bawab, A. Q., & Sharab, A. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009619666191116095847 · Cited by 36
Comparative Molecular Analysis of Cancer Behavior Cultured In Vitro, In Vivo, and Ex Vivo
Hum, N. R., Sebastian, A., Gilmore, S. F., He, W., Martin, K. A., Hinckley, A., Dubbin, K., Moya, M. L., Wheeler, E. K., Coleman, M. A., et al. (2020) · Cancers · doi:10.3390/cancers12030690 · Cited by 34
Barretto, E. C., Polan, D. M., Beevor-Potts, A., Lee, B., & Grewal, S. (2020) · Genetics · doi:10.1534/genetics.120.303219 · Cited by 34
Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agents
Rashed, F. B., Diaz‐Dussan, D., Mashayekhi, F., Macdonald, D., Nation, P. N., Yang, X., Sokhi, S., Stoica, C., Elsaidi, H. R. H., Ricardo, C., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102300 · Cited by 36
Reprogramming of central carbon metabolism in hepatocellular carcinoma
Xia, H., Huang, Z., Xu, Y., Yam, J. W. P., & Cui, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113485 · Cited by 40
Strigari, L., Torriani, F., Manganaro, L., Inaniwa, T., Dalmasso, F., Cirio, R., & Attili, A. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aa89ae · Cited by 36
Hypoxia-regulated microRNAs: the molecular drivers of tumor progression
Sawai, S., Wong, P., & Ramasamy, T. S. (2022) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2022.2088684 · Cited by 34
Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response
Memon, D., Dawson, K., Smowton, C., Wei, X., Dive, C., & Miller, C. J. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.20 · Cited by 36
Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs
Jackson, R. K., Liew, L. P., & Hay, M. P. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.004 · Cited by 36
Lost in application: Measuring hypoxia for radiotherapy optimisation
Thiruthaneeswaran, N., Bibby, B. A. S., Yang, L., Hoskin, P., Bristow, R. G., Choudhury, A., & West, C. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.039 · Cited by 35
Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 – 2021
Anduran, E., Dubois, L. J., Lambin, P., & Winum, J. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1954617 · Cited by 35
Nanotechnology‐mediated photodynamic therapy: Focus on overcoming tumor hypoxia
Moloudi, K., Abrahamse, H., & George, B. P. A. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1937 · Cited by 34
Shortcomings of Animal Models and the Rise of Engineered Human Cardiac Tissue
Fine, B. M., & Vunjak‐Novakovic, G. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00662 · Cited by 35
Sleeboom, J. J. F., den Toonder, J. M. J., & Sahlgren, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103047 · Cited by 35
Brewitz, L., Tumber, A., & Schofield, C. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012202 · Cited by 34
Human Cardiac Progenitor Cells Enhance Exosome Release and Promote Angiogenesis Under Physoxia
Dougherty, J. A., Patel, N. K., Kumar, N., Rao, S. G., Angelos, M. G., Singh, H., Cai, C., & Khan, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00130 · Cited by 34
The Role of single- and multi-walled Carbon Nanotube in Breast Cancer Treatment
Dizaji, B. F., Farboudi, A., Rahbar, A., Azarbaijan, M. H., & Asgary, M. R. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0019 · Cited by 34
Hypoxia-Induced Reactivity of Tumor-Associated Astrocytes Affects Glioma Cell Properties
Pantazopoulou, V., Jeannot, P., Rosberg, R., Berg, T. J., & Pietras, A. (2021) · Cells · doi:10.3390/cells10030613 · Cited by 35
Application of stem cells and exosomes in the treatment of intracerebral hemorrhage: an update
Zhou, J., Xiong, Y., Kang, X., Pan, Z., Zhu, Q., Goldbrunner, R., Stavrinou, L. C., Lin, S., Hu, W., Zheng, F., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02965-2 · Cited by 35
Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring
Mello, T., Simeone, I., & Galli, A. (2019) · Cells · doi:10.3390/cells8050417 · Cited by 34
Lyu, F., Li, Y., Yan, Z., He, Q., Cheng, L., Zhang, P., Liu, B., Liu, C., Song, Y., Xing, Y., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03398-4 · Cited by 33
Hill, R. M., Rocha, S., & Parsons, J. L. (2022) · Cancers · doi:10.3390/cancers14174130 · Cited by 33
Vahabi, M., Comandatore, A., Frańczak, M., Smolenski, R. T., Peters, G. J., Morelli, L., & Giovannetti, E. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.07.004 · Cited by 35
Crenn, V., Biteau, K., Amiaud, J., Dumars, C., Guiho, R., Vidal, L., Nail, L. L., Heymann, D., Moreau, A., Gouin, F., et al. (2017) · Europe PMC (PubMed Central) · Cited by 34
Bad neighbours: hypoxia and genomic instability in prostate cancer
Ashton, J., & Bristow, R. G. (2020) · British Journal of Radiology · doi:10.1259/bjr.20200087 · Cited by 32
Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32
Suri, G. S., Kaur, G., Carbone, G. M., & Shinde, D. A. (2023) · Cancer Reports · doi:10.1002/cnr2.1795 · Cited by 38
André‐Lévigne, D., Pignel, R., Boet, S., Jaquet, V., Kalbermatten, D. F., & Madduri, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042030 · Cited by 35
Hypoxic Jumbo Spheroids On-A-Chip (HOnAChip): Insights into Treatment Efficacy
Refet-Mollof, E., Najyb, O., Chermat, R., Glory, A., Lafontaine, J., Wong, P., & Gervais, T. (2021) · Cancers · doi:10.3390/cancers13164046 · Cited by 34
Sadozai, H., Acharjee, A., Kayani, H. Z., Gruber, T., Gorczynski, R. M., & Burke, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1360629 · Cited by 32
Paul‐Gilloteaux, P., Potiron, V. A., Delpon, G., Supiot, S., Chiavassa, S., Paris, F., & Costes, S. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-01757-6 · Cited by 33
Fischer, A. P., & Miles, S. L. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.017 · Cited by 32
The Zebrafish Xenograft Platform—A Novel Tool for Modeling KSHV-Associated Diseases
Pringle, E. S., Wertman, J. N., Melong, N., Coombs, A. J., Young, A. L., O’Leary, D. R., Veinotte, C. J., Robinson, C.-A., Ha, M. N., Dellaire, G., et al. (2019) · Viruses · doi:10.3390/v12010012 · Cited by 31
Partially Fluorinated Copolymers as Oxygen Sensitive 19F MRI Agents
Taylor, N. G., Chung, S. H., Kwansa, A. L., Johnson, R. R., Teator, A. J., Milliken, N. J. B., Koshlap, K. M., Yingling, Y. G., Lee, Y. Z., & Leibfarth, F. A. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001505 · Cited by 31
Liu, H., Jiwen, Y., Guo, H., Cai, X., Jiang, Y., Lin, M., Jiang, X., Leung, W., & Xu, C. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00758 · Cited by 31
Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization
Lucky, S. S., Law, M. W.-M., Lui, M. H., Mong, J. C. Y., Shi, J., Yu, S. W.-K., Yoon, D. K., Djeng, S.-K., Wang, J., Lim, C. M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.622244 · Cited by 31
Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunitiesPreprint
Shen, M., & Kang, Y. (2020) · Genes & Development · doi:10.1101/gad.343251.120 · Cited by 31
Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
Khouzam, R. A., Lehn, J., Mayr, H., Clavien, P., Wallace, M. B., Ducreux, M. P., Limani, P., & Chouaïb, S. (2023) · Cancers · doi:10.3390/cancers15041235 · Cited by 33
Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer
Shah, V. M., Nguyen, D. X., Fatease, A. M. A., Patel, P. B., Cote, B., Woo, Y., Gheewala, R., Pham, Y., Huynh, M. G., Gannett, C., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.021 · Cited by 30
Chou, Y., Lin, C.-Y., Wen, J.-W., Hung, L.-C., Chang, Y.-F., Yang, C., Wu, L.-C., & Ho, J. A. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00786-8 · Cited by 30
Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
Pandkar, M. R., Dhamdhere, S. G., & Shukla, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188553 · Cited by 33
Approaches to modeling chemical reaction pathways in radiobiology
Wardman, P. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2033342 · Cited by 34
Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release
Quintana, J. M., Prado, D. E. A., Hu, H., Scott, E., Luthria, G., Pai, S. I., Parangi, S., Weissleder, R., & Miller, M. A. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00174 · Cited by 30
Wang, Y., Wang, H., Li, J., Entenberg, D. R., Xue, A., Wang, W., & Condeelis, J. S. (2016) · IntraVital · doi:10.1080/21659087.2016.1187803 · Cited by 30
Collagen Fiber Architecture Regulates Hypoxic Sarcoma Cell Migration
Lewis, D. M., Tang, V., Jain, N., Isser, A., Xia, Z., & Gerecht, S. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00056 · Cited by 30
Travelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 31
Shedding Light on Chemoresistance: The Perspective of Photodynamic Therapy in Cancer Management
Cabral, F. V., Quílez-Alburquerque, J., Roberts, H. J., & Hasan, T. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073811 · Cited by 29
Ma, Y., Deng, Y., Xue, W., Ji, X., & Li, M. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c06533 · Cited by 30
PQM-1 controls hypoxic survival via regulation of lipid metabolism
Heimbucher, T., Hog, J., Gupta, P., & Murphy, C. T. (2020) · Nature Communications · doi:10.1038/s41467-020-18369-w · Cited by 29
Zhang, J., Ma, X., & Fan, D. (2021) · Foods · doi:10.3390/foods10061195 · Cited by 31
Sukei, T., Palma, E., & Urbani, L. (2021) · Cancers · doi:10.3390/cancers13215586 · Cited by 29
The Therapeutic Potential of FLASH-RT for Pancreatic Cancer
Okoro, C. M., Schüler, E., & Taniguchi, C. M. (2022) · Cancers · doi:10.3390/cancers14051167 · Cited by 29
Gong, X., Qiu, T., Feng, L., Yang, K., Dai, S., Zhou, J., Zhang, X., Chen, S., & Ji, Y. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00756-4 · Cited by 29
Su, Q., Wang, J., Fan, M., Ghauri, M. A., Ullah, A., Wang, B., Dai, B., Zhan, Y., Zhang, D., & Zhang, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15056 · Cited by 31
Horst, F., Bodenstein, E., Brand, M., Hans, S., Karsch, L., Leßmann, E., Löck, S., Schürer, M., Pawelke, J., & Beyreuther, E. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110197 · Cited by 28
Kamlund, S., Strand, D., Janicke, B., Alm, K., & Oredsson, S. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1380131 · Cited by 28
Feng, J., Byrne, N. M., Al-Jamal, W. T., & Coulter, J. A. (2019) · Cancers · doi:10.3390/cancers11121989 · Cited by 29
Nagy, P., Dóka, É., Ida, T., & Akaike, T. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8077 · Cited by 28
Modeling the photodynamic effect in 2D versus 3D cell culture under normoxic and hypoxic conditions
Kucińska, M., Plewiński, A., Szczołko, W., Kaczmarek, M., Gośliński, T. A., & Murias, M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.304 · Cited by 28
Cardiac Exosomes in Ischemic Heart Disease—A Narrative Review
Røsand, Ø., & Høydal, M. A. (2021) · Diagnostics · doi:10.3390/diagnostics11020269 · Cited by 28
Inaniwa, T., Kanematsu, N., Shinoto, M., Koto, M., & Yamada, S. (2021) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ac29cc · Cited by 28
Metadata
- Authors
- McKeown, S. R.
- Affiliations
- University of Ulster (GB)
- Corresponding author
- McKeown, S R
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 87
- Issue
- 1035
- Pages
- 20130676
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- PMC
- PMC4064601
- OpenAlex
- W2018722597
- Cited by
- 1,050
- References
- 126
- Citations by year
- 2026: 84 · 2025: 122 · 2024: 129 · 2023: 139 · 2022: 137 · 2021: 152 · 2020: 107 · 2019: 68 · 2018: 56 · 2017: 33 · 2016: 13 · 2015: 5 · 2014: 4
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Radiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor hypoxia, tumor oxygenation, normoxia, treatment response, prostate cancer, pancreatic cancer, malignant progression
- MeSH terms
- Animals, Hypoxia, Humans, Male, Neoplasms, Oxygen, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
